Radiolabeled Compounds for Diagnosis and Treatment of Cancer - Mdpi Ag - Books - MDPI AG - 9783036524276 - December 6, 2021
In case cover and title do not match, the title is correct

Radiolabeled Compounds for Diagnosis and Treatment of Cancer

Price
$ 62.49
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jun 25 - Jul 7
Add to your iMusic wish list

Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals.

Media Books     Hardcover Book   (Book with hard spine and cover)
Released December 6, 2021
ISBN13 9783036524276
Publishers MDPI AG
Pages 262
Dimensions 169 × 244 × 22 mm   ·   766 g
Language English  

More by Mdpi Ag

Show all

Mere med samme udgiver